Register entry
Helsinn Therapeutics (U.S.), Inc.
- Registered sites
- 0
- Drug products
- 4
- Live patents
- 44
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
44Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| AKYNZEO | FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE | Nov 2030 |
| AKYNZEO | FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE | Dec 2030 |
| AKYNZEO | NETUPITANT; PALONOSETRON HYDROCHLORIDE | Sept 2031 |
| AKYNZEO | FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE | May 2032 |
| AKYNZEO | NETUPITANT; PALONOSETRON HYDROCHLORIDE | Sept 2035 |
| AKYNZEO | FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE | Jun 2037 |
| TRUSELTIQ | INFIGRATINIB PHOSPHATE | Aug 2028 |
| TRUSELTIQ | INFIGRATINIB PHOSPHATE | Aug 2029 |
| TRUSELTIQ | INFIGRATINIB PHOSPHATE | Dec 2034 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AKYNZEO | Netupitant and Palonosetron | CAPSULE | NDA |
| AKYNZEO | Fosnetupitant and Palonosetron | INJECTION | NDA |
| AKYNZEO | Fosnetupitant and Palonosetron | INJECTION | NDA |
| VALCHLOR | mechlorethamine hydrochloride | GEL | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.